4-carbamoylimidazolium 5-olate and Leukemia, Smoldering

4-carbamoylimidazolium 5-olate has been researched along with Leukemia, Smoldering in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirano, M; Kimura, K; Masaoka, T; Ogawa, M; Ohno, R; Uzuka, Y; Yamada, K	1

Trials

1 trial(s) available for 4-carbamoylimidazolium 5-olate and Leukemia, Smoldering

Article	Year
[Phase II study of SM-108 (4-carbamoylimidazolium-5-olate) in hematological malignancies]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; Child; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Imidazoles; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myelomonocytic, Chronic; Lymphoma; Male; Middle Aged; Multicenter Studies as Topic; Myelodysplastic Syndromes; Polycythemia Vera; Remission Induction	1989

Article

Year

[Phase II study of SM-108 (4-carbamoylimidazolium-5-olate) in hematological malignancies].

Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:1

Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; Child; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Imidazoles; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myelomonocytic, Chronic; Lymphoma; Male; Middle Aged; Multicenter Studies as Topic; Myelodysplastic Syndromes; Polycythemia Vera; Remission Induction

1989